表紙:免疫組織化学染色 (IHC) の世界市場 (~2026年):製品 (抗体・試薬・装置・キット)・用途 (診断 (癌・感染症・自己免疫疾患)・研究・法医学)・エンドユーザー (病院・診断ラボ・学術)・地域別
市場調査レポート
商品コード
1036664

免疫組織化学染色 (IHC) の世界市場 (~2026年):製品 (抗体・試薬・装置・キット)・用途 (診断 (癌・感染症・自己免疫疾患)・研究・法医学)・エンドユーザー (病院・診断ラボ・学術)・地域別

Immunohistochemistry (IHC) Market by Product (Antibodies, Reagents, Equipment, Kits), Application (Diagnostics (Cancer, Infectious, Autoimmune Diseases), Research, Forensic), End user (Hospitals, Diangostic labs, Academia) - Global Forecast to 2026

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 339 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
免疫組織化学染色 (IHC) の世界市場 (~2026年):製品 (抗体・試薬・装置・キット)・用途 (診断 (癌・感染症・自己免疫疾患)・研究・法医学)・エンドユーザー (病院・診断ラボ・学術)・地域別
出版日: 2021年11月11日
発行: MarketsandMarkets
ページ情報: 英文 339 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の免疫組織化学染色 (IHC) の市場規模は予測期間中7.7%のCAGRで推移し、2021年の23億米ドルから、2026年には33億米ドルの規模に成長すると予測されています。

高齢者人口の増加とそれに伴う慢性疾患や感染症の有病率の上昇、IHCの技術的進歩、IHC検査に対する償還などの要因が同市場の成長を推進しています。一方で、参入事業者による統合の進展が予測期間中の成長を抑制すると予測されています。

製品別で見ると、キット製品の部門が2020年に約12%のシェアを示し、予測期間中も最大の成長を示すと予測されています。診断ラボ、病院、研究機関などのエンドユーザーの間では、単一のプロバイダーによる完全なソリューションへの需要が高まっています。また、すぐに使えるキットはIHCプロセスを簡素化するため、同部門の成長が見込まれています。

当レポートでは、世界の免疫組織化学染色 (IHC) の市場を調査し、市場の定義と概要、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、法規制環境、技術・特許の動向、市場規模の推移・予測、製品・用途・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • 範囲/シナリオ
  • COVID-19の影響
  • 顧客の事業に影響を与える動向・ディスラプション
  • 価格分析
  • バリューチェーン分析
  • エコシステム分析
  • 技術分析
  • 特許分析
  • 規制分析
  • ポーターのファイブフォース分析

第6章 免疫組織化学染色市場:製品別

  • 抗体
    • 一次抗体
    • 二次抗体
  • 試薬
    • 組織学的染色
    • ブロッキング血清試薬
    • 発色基質
    • 固定試薬
    • 希釈剤
    • 有機溶剤
    • タンパク質分解酵素
    • その他
  • 装置
    • スライド染色システム
    • 組織処理システム
    • スライドスキャナー
    • その他
  • キット
    • ヒト免疫組織化学染色キット
    • 動物免疫組織化学染色キット

第7章 免疫組織化学染色市場:用途別

  • 診断
    • 感染症
    • 腎疾患
    • 自己免疫疾患
    • 神経疾患
    • その他
  • 研究
    • 医薬品開発・試験
    • その他
  • 法医学

第8章 免疫組織化学染色市場:エンドユーザー別

  • 病院・診断ラボ
  • 学術・研究機関
  • その他

第9章 免疫組織化学染色市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第10章 競合情勢

  • 概要
  • 主要企業の戦略
  • 市場シェア分析
  • 主要企業の収益シェア分析
  • 企業評価クアドラント
  • 企業評価クアドラント:新興企業/中小企業
  • 企業の製品フットプリント
  • 企業の地理的フットプリント
  • 競合シナリオ

第11章 企業プロファイル

  • 主要企業
    • F. HOFFMANN-LA ROCHE AG
    • DANAHER CORPORATION
    • AGILENT TECHNOLOGIES, INC.
    • MERCK KGAA
    • BIO-RAD LABORATORIES, INC.
    • BIO-TECHNE CORPORATION
    • ABCAM PLC
    • BECTON, DICKINSON AND COMPANY
    • PERKINELMER, INC.
    • TAKARA BIO, INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • PHC HOLDINGS CORPORATION
    • CELL SIGNALING TECHNOLOGY, INC.
    • BIO SB, INC.
    • MILTENYI BIOTEC
    • CANDOR BIOSCIENCE GMBH
    • SAKURA FINETEK JAPAN CO., LTD.
  • その他の企業
    • EAGLE BIOSCIENCES, INC.
    • BIOCARE MEDICAL, LLC
    • ELABSCIENCE, INC.
    • BIO-GENEX LABORATORIES
    • DIAGNOSTIC BIOSYSTEMS, INC.
    • BIOVISION, INC.
    • ROCKLAND IMMUNOCHEMICALS, INC.
    • GENEMED BIOTECHNOLOGIES, INC.

第12章 付録

目次
Product Code: BT 4780

The global immunohistochemistry market is projected to reach USD 3.3 billion by 2026 from USD 2.3 billion in 2021, at a CAGR of 7.7% during the forecast period of 2021 to 2026. Market growth is largely driven by the rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases, technological advancements in IHC, and availability of reimbursements for IHC tests. However, the high degree of consolidation in the by the major market players is expected to restrain the growth of this market during the forecast period.

"The Kits product segment accounted for the highest growth rate in the immunohistochemistry market, by product, during the forecast period"

In 2020, the Kits product segment accounted for the share of around 12% of the immunohistochemsitry market. The demand for complete solutions from a single provider, like closed-system reagents with calibrated measurements of the required quantity of reagents and controls among diagnostic laboratories, hospitals, research institutes, and other end users, is growing. Moreover, ready-to-use kits simplify the IHC process by rectifying the initial time-consuming selections of primary antibodies and appropriate stains. This is fueling the growth of the immunohistochemistry kits market.

"Diagnostic applications segment accounted for the largest share of the application segment"

Based on application, the IHC market is segmented into diagnostic, research, and forensic applications. The Diagnostic application segment dominated this market in 2020 and is estimated to register the highest growth during the forecast period. The growth of this segment is majorly attributed to factors such as the advantages of IHC over traditionally used special enzyme staining techniques that identify only a limited number of proteins, enzymes, and tissue structures. Therefore, IHC has become a crucial technique and is widely used for medical research as well as clinical diagnostics.

"Hospitals & Diagnostic Laboratories segment accounted for the largest share of the end user segment"

Based on end user, the IHC market is segmented into hospitals & diagnostic laboratories, academic & research institutes, and other end users. The hospitals & diagnostic laboratories segment accounted for the largest share (74.8%) of the IHC market in 2020. The increasing number of specialty diagnostic tests performed in hospital laboratories, the rising number of in-house diagnostic procedures in hospitals, and the increasing trend of establishing in-house diagnostic capabilities in hospitals to provide time-bound and affordable patient services are factors driving the growth of this market segment.

"Asia Pacific: The fastest-growing region in the immunohistochemistry market"

Based on the region, the immunohistochemistry market is broadly segmented into North America, Europe, Asia-Pacific and Rest of the World. APAC is expected to register the fastest growth rate during the forecast period owing to several factors, including increasing disposable income, rising healthcare spending, growing demand for quality medical care, and increasing investments by pharmaceutical and biopharmaceutical companies. The rising prevalence of chronic ailments, rapidly increasing geriatric population, growing academic and government investments in diagnostic research, and the presence of many market players are the other major factors driving the growth of the immunohistochemistry market in APAC.

The primary interviews conducted for this report can be categorized as follows:

  • By Respondent: Supply Side- 80% and Demand Side 20%
  • By Designation: Managers - 55%, CXOs - 20%, and Executives - 25%
  • By Region: North America -50%, Europe -20%, Asia-Pacific -20%, RoW -10%

Lists of Companies Profiled in the Report:

  • F. Hoffman-La Roche AG (Switzerland)
  • Danaher Corporation (US)
  • Agilent Technologies, Inc. (US)
  • Merck KGaA (Germany)
  • Bio-Rad Laboratories, Inc. (US)
  • Bio-Techne Corporation (US)
  • Abcam plc (UK)
  • Becton, Dickinson and Company (US)
  • PerkinElmer, Inc. (US)
  • Takara Bio, Inc. (Japan)
  • Thermo Fisher Scientific, Inc. (US)
  • PHC Holdings Corporation (Japan)
  • Cell Signaling Technology, Inc. (US)
  • Bio SB, Inc. (US)
  • Miltenyi Biotec (Germany)
  • CANDOR Bioscience GmbH (Germany)
  • Sakura Finetek Japan Co., Ltd. (Japan)
  • Eagle Biosciences, Inc. (US)
  • Biocare Medical, LLC (US)
  • Elabscience, Inc. (China)
  • Biogenex Laboratories (US)
  • Diagnostic Biosystems, Inc. (US)
  • BioVision Inc. (US)
  • Rockland Immunochemicals, Inc. (US)
  • Genemed Biotechnologies, Inc. (US)

Research Coverage:

This report provides a detailed picture of the immunohistochemistry market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall immunohistochemsitry market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, trends, challenges and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • TABLE 1 IMMUNOHISTOCHEMISTRY MARKET: INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
    • 2.1.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARIES: IHC MARKET
  • 2.2 MARKET ESTIMATION METHODOLOGY
    • FIGURE 3 IHC MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS) 2020
    • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2020
    • 2.2.1 INSIGHTS FROM PRIMARY EXPERTS
    • FIGURE 5 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • 2.3 MARKET GROWTH RATE PROJECTIONS
    • FIGURE 6 IHC MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
    • FIGURE 7 IHC MARKET (DEMAND-SIDE): GROWTH ANALYSIS OF DEMAND-SIDE DRIVERS
  • 2.4 DATA TRIANGULATION
    • FIGURE 8 DATA TRIANGULATION METHODOLOGY
  • 2.5 RESEARCH ASSUMPTIONS
    • 2.5.1 COVID-19 SPECIFIC ASSUMPTIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 9 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
    • FIGURE 10 IMMUNOHISTOCHEMISTRY MARKET SHARE, BY APPLICATION, 2020
    • FIGURE 11 IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2021-2026
    • FIGURE 12 GEOGRAPHICAL SNAPSHOT OF IMMUNOHISTOCHEMISTRY MARKET

4 PREMIUM INSIGHTS

  • 4.1 IMMUNOHISTOCHEMISTRY MARKET OVERVIEW
    • FIGURE 13 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SHARE, BY END USER AND COUNTRY (2020)
    • FIGURE 14 HOSPITALS & DIAGNOSTIC LABORATORIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC IHC MARKET IN 2020
  • 4.3 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE
    • FIGURE 15 PRIMARY ANTIBODIES SEGMENT TO LEAD IHC ANTIBODIES MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 16 IHC MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • TABLE 2 IHC MARKET: IMPACT ANALYSIS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases
    • TABLE 3 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019-2050)
    • FIGURE 17 CANCER INCIDENCE, BY REGION AND TYPE OF CANCER, 2020
      • 5.2.1.2 Technological advancements in IHC
      • 5.2.1.3 Availability of reimbursements for IHC tests
    • TABLE 4 CPT CODES FOR IHC PROCEDURES
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High degree of consolidation
    • TABLE 5 MAJOR ACQUISITIONS IN THE MARKET, 2018-2021
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing demand for personalized medicine
      • 5.2.3.2 Growing significance of companion diagnostics
      • 5.2.3.3 Growth opportunities in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Dearth of skilled professionals
    • TABLE 6 NUMBER OF PATHOLOGISTS PER 100,000 POPULATION, BY COUNTRY, 2018
      • 5.2.4.2 Product failures and recalls
  • 5.3 RANGES/SCENARIO
    • FIGURE 18 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF IHC MARKET
  • 5.4 IMPACT OF COVID-19 OUTBREAK ON IHC MARKET
    • FIGURE 19 IHC MARKET SCENARIO WITH AND WITHOUT COVID-19 IMPACT, 2019-2021
  • 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 20 REVENUE SHIFT & NEW POCKET FOR IHC PROVIDERS
  • 5.6 PRICING ANALYSIS
    • TABLE 7 AVERAGE SELLING PRICE OF SOME IHC EQUIPMENT, REAGENTS, AND KITS (2020)
  • 5.7 VALUE CHAIN ANALYSIS
    • FIGURE 21 VALUE CHAIN ANALYSIS OF IHC MARKET: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
  • 5.8 ECOSYSTEM ANALYSIS
    • FIGURE 22 ECOSYSTEM ANALYSIS: IHC MARKET
    • TABLE 8 SUPPLY CHAIN ECOSYSTEM
  • 5.9 TECHNOLOGY ANALYSIS
  • 5.10 PATENT ANALYSIS
    • FIGURE 23 PATENT GRANTED FOR IHC IN LAST 10 YEARS
    • TABLE 9 INDICATIVE LIST OF PATENTS IN IHC MARKET
  • 5.11 REGULATORY ANALYSIS
    • 5.11.1 US
    • TABLE 10 US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
    • FIGURE 24 US: REGULATORY PROCESS FOR IVD DEVICES
    • 5.11.2 CANADA
    • FIGURE 25 CANADA: REGULATORY PROCESS FOR IVD DEVICES
    • 5.11.3 EUROPE
    • TABLE 11 EUROPE: CLASSIFICATION OF IVD DEVICES
    • FIGURE 26 EUROPE: REGULATORY PROCESS FOR IVD DEVICES
    • 5.11.4 JAPAN
    • FIGURE 27 JAPAN: REGULATORY PROCESS FOR IVD DEVICES
    • TABLE 12 JAPAN: CLASSIFICATION OF IVD REAGENTS
    • TABLE 13 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.11.5 CHINA
    • TABLE 14 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.11.6 INDIA
    • FIGURE 28 INDIA: REGULATORY PROCESS FOR IVD DEVICES
    • 5.11.7 BRAZIL
    • FIGURE 29 BRAZIL: REGULATORY PROCESS FOR IVD DEVICES
  • 5.12 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 15 IHC MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.12.1 THREAT OF NEW ENTRANTS
    • 5.12.2 THREAT OF SUBSTITUTES
    • 5.12.3 BARGAINING POWER OF BUYERS
    • 5.12.4 BARGAINING POWER OF SUPPLIERS
    • 5.12.5 COMPETITIVE RIVALRY AMONG EXISTING PLAYERS

6 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 16 IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 6.2 ANTIBODIES
    • TABLE 17 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 18 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 19 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 20 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 21 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 22 IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • 6.2.1 PRIMARY ANTIBODIES
      • 6.2.1.1 Wide applications in diagnostics and research to support demand for primary antibodies
    • TABLE 23 IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 24 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 25 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 26 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 27 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR PRIMARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
    • 6.2.2 SECONDARY ANTIBODIES
      • 6.2.2.1 Signal amplification through conjugation and comparatively easy manufacturing to drive market for secondary antibodies
    • TABLE 28 IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 29 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 30 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 31 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 32 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SECONDARY ANTIBODIES, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 REAGENTS
    • TABLE 33 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 34 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 35 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 36 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 37 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 38 IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • 6.3.1 HISTOLOGICAL STAINS
      • 6.3.1.1 Developments in concurrent detection of multiple antigenic sites within single tissue specimen and cancer disease progression studies to propel market growth
    • TABLE 39 IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 40 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 41 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 42 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 43 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR HISTOLOGICAL STAINS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.2 BLOCKING SERA AND REAGENTS
      • 6.3.2.1 Blocking sera and reagents prevent nonspecific binding and reduce background noise and potentially false-positive results
    • TABLE 44 IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 46 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 47 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 48 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR BLOCKING SERA AND REAGENTS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.3 CHROMOGENIC SUBSTRATES
      • 6.3.3.1 Chromogenic substrates segment to register highest growth during forecast period
    • TABLE 49 IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 50 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 51 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 52 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 53 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR CHROMOGENIC SUBSTRATES, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.4 FIXATION REAGENTS
      • 6.3.4.1 North America is largest market for fixation reagents
    • TABLE 54 IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 55 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 56 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 57 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 58 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR FIXATION REAGENTS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.5 DILUENTS
      • 6.3.5.1 Diluents are used to prepare antibody solutions
    • TABLE 59 IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 60 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 61 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 62 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 63 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DILUENTS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.6 ORGANIC SOLVENTS
      • 6.3.6.1 Organic solvents prevent physical damage in specimens and improve clarity while visualizing tissue samples
    • TABLE 64 IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 65 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 66 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 67 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 68 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ORGANIC SOLVENTS, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.7 PROTEOLYTIC ENZYMES
      • 6.3.7.1 Proteolytic enzymes improve accessibility of target antibodies
    • TABLE 69 IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 70 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 71 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 72 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 73 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR PROTEOLYTIC ENZYMES, BY REGION, 2019-2026 (USD MILLION)
    • 6.3.8 OTHER REAGENTS
      • 6.3.8.1 Other reagents include antigen retrieval solutions, stabilizers, controls, and mounting solutions
    • TABLE 74 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 75 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 76 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 77 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 78 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER REAGENTS, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 EQUIPMENT
    • TABLE 79 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 80 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 81 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 82 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 83 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 84 IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • 6.4.1 SLIDE-STAINING SYSTEMS
      • 6.4.1.1 Development of high throughput staining systems to drive market growth
    • TABLE 85 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 86 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 87 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 88 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 89 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE-STAINING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • 6.4.2 TISSUE PROCESSING SYSTEMS
      • 6.4.2.1 Technological advancements and need for automation due to shortage of skilled workforce to drive market growth
    • TABLE 90 IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 91 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 92 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 93 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 94 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR TISSUE PROCESSING SYSTEMS, BY REGION, 2019-2026 (USD MILLION)
    • 6.4.3 SLIDE SCANNERS
      • 6.4.3.1 Development of advanced multiplexed IHC scanners to drive market growth
    • TABLE 95 IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 96 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 97 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 98 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 99 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR SLIDE SCANNERS, BY REGION, 2019-2026 (USD MILLION)
    • 6.4.4 OTHER EQUIPMENT
    • TABLE 100 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 101 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 102 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 103 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 104 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER EQUIPMENT, BY REGION, 2019-2026 (USD MILLION)
  • 6.5 KITS
    • TABLE 105 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 106 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 107 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 108 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 109 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 110 IMMUNOHISTOCHEMISTRY MARKET FOR KITS, BY TYPE, 2019-2026 (USD MILLION)
    • 6.5.1 HUMAN IMMUNOHISTOCHEMISTRY KITS
      • 6.5.1.1 Increasing focus on cancer research to fuel market growth
    • TABLE 111 IMMUNOHISTOCHEMISTRY MARKET FOR HUMAN IMMUNOHISTOCHEMISTRY KITS, BY REGION, 2019-2026 (USD MILLION)
    • 6.5.2 ANIMAL IMMUNOHISTOCHEMISTRY KITS
      • 6.5.2.1 Increasing preclinical drug testing to drive market growth
    • TABLE 112 IMMUNOHISTOCHEMISTRY MARKET FOR ANIMAL IMMUNOHISTOCHEMISTRY KITS, BY REGION, 2019-2026 (USD MILLION)

7 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
    • TABLE 113 IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 7.2 DIAGNOSTIC APPLICATIONS
    • TABLE 114 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 115 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 116 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 117 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 118 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 119 IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • 7.2.1 CANCER
      • 7.2.1.1 Growing use of IHC tests for cancer diagnostics to fuel market growth
    • TABLE 120 COMMON CANCER MARKERS FOR IMMUNOHISTOCHEMICAL DIAGNOSIS
    • TABLE 121 IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 122 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 123 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 124 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 125 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR CANCER, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.2 INFECTIOUS DISEASES
      • 7.2.2.1 Growing prevalence of infectious diseases and rising awareness of early diagnosis to propel market growth
    • TABLE 126 COMMON INFECTIOUS DISEASE MARKERS/ANTIGENS FOR IMMUNOHISTOCHEMICAL DIAGNOSIS
    • TABLE 127 IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 128 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 129 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 130 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 131 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR INFECTIOUS DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.3 NEPHROLOGICAL DISEASES
      • 7.2.3.1 Wide application of IHC in transplant rejection expected to support market growth
    • TABLE 132 IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 133 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 134 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 135 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 136 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEPHROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.4 AUTOIMMUNE DISEASES
      • 7.2.4.1 Availability of numerous primary antibodies and rapid processing of results makes IHC a favorable diagnostic approach
    • TABLE 137 IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 138 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 139 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 140 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 141 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR AUTOIMMUNE DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.5 NEUROLOGICAL DISEASES
      • 7.2.5.1 Increasing global burden of neurological diseases to propel market growth
    • TABLE 142 COMMON IMMUNOHISTOCHEMISTRY MARKERS FOR CENTRAL NERVOUS SYSTEM
    • TABLE 143 IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 144 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 145 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 146 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 147 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR NEUROLOGICAL DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.6 OTHER DISEASES
    • TABLE 148 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 149 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 150 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 151 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 152 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER DISEASES, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 RESEARCH APPLICATIONS
    • TABLE 153 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 154 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 155 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 156 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 157 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 158 IMMUNOHISTOCHEMISTRY MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2019-2026 (USD MILLION)
    • 7.3.1 DRUG DEVELOPMENT & TESTING
      • 7.3.1.1 Quantitative image analysis makes IHC techniques ideal for drug testing
    • TABLE 159 IMMUNOHISTOCHEMISTRY MARKET FOR DRUG DEVELOPMENT & TESTING, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.2 OTHER RESEARCH APPLICATIONS
    • TABLE 160 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER RESEARCH APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 FORENSIC APPLICATIONS
    • TABLE 161 IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 162 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 163 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 164 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 165 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR FORENSIC APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

8 IMMUNOHISTOCHEMISTRY MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 166 IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 8.2 HOSPITALS & DIAGNOSTIC LABORATORIES
    • 8.2.1 INCREASING INCIDENCE OF CANCER AND INFECTIOUS DISEASES TO INCREASE TESTING VOLUME IN CLINICAL LABORATORIES
    • TABLE 167 IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 168 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 169 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 170 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 171 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 ACADEMIC & RESEARCH INSTITUTES
    • 8.3.1 INCREASING USE OF IHC TESTS FOR DRUG DEVELOPMENT AND DISEASES DIAGNOSIS TO SUPPORT MARKET GROWTH
    • TABLE 172 IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 173 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 174 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 175 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 176 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 177 IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 178 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 179 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 180 APAC: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 181 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)

9 IMMUNOHISTOCHEMISTRY MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 30 IMMUNOHISTOCHEMISTRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 182 IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 31 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
    • TABLE 183 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 184 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 185 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 186 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 187 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 188 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 189 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 190 NORTH AMERICA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 US is largest country-level market for immunohistochemistry
    • TABLE 191 RECENT DEVELOPMENTS IN US IHC MARKET
    • TABLE 192 US: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 193 US: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 194 US: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 195 US: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 196 US: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 197 US: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 198 US: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Increasing cancer cases in Canada to propel market growth
    • TABLE 199 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 200 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 201 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 202 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 203 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 204 CANADA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 205 CANADA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 206 RECENT DEVELOPMENTS IN EUROPEAN IHC MARKET
    • TABLE 207 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 208 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 209 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 210 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 211 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 212 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 213 EUROPE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 214 EUROPE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany to dominate European IHC market
    • TABLE 215 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 216 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 217 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 218 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 219 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 220 GERMANY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 221 GERMANY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Increasing use of IHC in cancer diagnosis and research to drive market growth
    • TABLE 222 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 223 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 224 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 225 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 226 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 227 FRANCE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 228 FRANCE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Increasing number of cancer research studies to support market growth
    • TABLE 229 UK: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 230 UK: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 231 UK: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 232 UK: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 233 UK: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 234 UK: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 235 UK: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 High incidence of cancer and rising geriatric population to support market growth in Italy
    • TABLE 236 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 237 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 238 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 239 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 240 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 241 ITALY: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 242 ITALY: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Increasing demand for personalized medicine will drive demand for IHC tests to find potential biomarkers
    • TABLE 243 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 244 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 245 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 246 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 247 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 248 SPAIN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 249 SPAIN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 250 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 251 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 252 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 253 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 254 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 255 ROE: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 256 ROE: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 32 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET SNAPSHOT
    • TABLE 257 RECENT DEVELOPMENTS IN ASIA PACIFIC IHC MARKET
    • TABLE 258 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 259 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 260 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 261 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 262 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 263 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 264 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 265 ASIA PACIFIC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan to dominate Asia Pacific immunohistochemistry market
    • TABLE 266 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 267 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 268 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 269 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 270 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 271 JAPAN: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 272 JAPAN: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 China to register highest growth during forecast period
    • TABLE 273 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 274 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 275 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 276 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 277 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 278 CHINA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 279 CHINA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 India is key destination for high-end pathology and diagnostic services
    • TABLE 280 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 281 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 282 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 283 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 284 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 285 INDIA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 286 INDIA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 287 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 288 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 289 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 290 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 291 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 292 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 293 ROAPAC: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 294 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY REGION, 2019-2026 (USD MILLION)
    • TABLE 295 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 296 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 297 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 298 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 299 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 300 ROW: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 301 ROW: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.1 LATIN AMERICA
      • 9.5.1.1 Increasing incidence of cancer in Latin America driving market growth
    • TABLE 302 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 303 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 304 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 305 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 306 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 307 LATAM: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 308 LATAM: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 9.5.2 MIDDLE EAST AND AFRICA
      • 9.5.2.1 Government initiatives focused on boosting healthcare infrastructure development to drive market growth
    • TABLE 309 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 310 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR ANTIBODIES, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 311 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR REAGENTS, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 312 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR EQUIPMENT, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 313 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 314 MEA: IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS, BY DISEASE, 2019-2026 (USD MILLION)
    • TABLE 315 MEA: IMMUNOHISTOCHEMISTRY MARKET, BY END USER, 2019-2026 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
    • FIGURE 33 KEY PLAYERS STRATEGIES IN IMMUNOHISTOCHEMISTRY MARKET, 2019- 2021
  • 10.3 MARKET SHARE ANALYSIS
    • FIGURE 34 IMMUNOHISTOCHEMISTRY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
  • 10.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 35 TOP MARKET PLAYERS DOMINATED IMMUNOHISTOCHEMISTRY MARKET FOR PAST 5 YEARS
  • 10.5 COMPANY EVALUATION QUADRANT
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE
    • 10.5.4 EMERGING COMPANIES
    • FIGURE 36 IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 10.6 COMPANY EVALUATION QUADRANT: START-UPS/SMES
    • 10.6.1 PROGRESSIVE COMPANIES
    • 10.6.2 STARTING BLOCKS
    • 10.6.3 RESPONSIVE COMPANIES
    • 10.6.4 DYNAMIC COMPANIES
    • FIGURE 37 IMMUNOHISTOCHEMISTRY MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
  • 10.7 COMPANY PRODUCT FOOTPRINT
    • TABLE 316 PRODUCT PORTFOLIO ANALYSIS: IMMUNOHISTOCHEMISTRY MARKET (2020)
  • 10.8 COMPANY GEOGRAPHIC FOOTPRINT
    • TABLE 317 GEOGRAPHIC REVENUE MIX: IMMUNOHISTOCHEMISTRY MARKET (2020)
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 IMMUNOHISTOCHEMISTRY MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2019-MARCH 2021
    • 10.9.2 IMMUNOHISTOCHEMISTRY MARKET: DEALS, JANUARY 2019-MARCH 2021
    • 10.9.3 IMMUNOHISTOCHEMISTRY MARKET: OTHER DEVELOPMENTS, JANUARY 2019-MARCH 2021

11 COMPANY PROFILES

  • 11.1 KEY COMPANIES
  • (Business overview, Products and Services offered, Recent developments, MNM view)**
    • 11.1.1 F. HOFFMANN-LA ROCHE AG
    • TABLE 318 F. HOFFMANN-LA ROCHE AG: BUSINESS OVERVIEW
    • FIGURE 38 F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2020)
    • 11.1.2 DANAHER CORPORATION
    • TABLE 319 DANAHER CORPORATION: BUSINESS OVERVIEW
    • FIGURE 39 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.3 AGILENT TECHNOLOGIES, INC.
    • TABLE 320 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 40 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.4 MERCK KGAA
    • TABLE 321 MERCK KGAA: BUSINESS OVERVIEW
    • FIGURE 41 MERCK KGAA: COMPANY SNAPSHOT (2020)
    • 11.1.5 BIO-RAD LABORATORIES, INC.
    • TABLE 322 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 42 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.6 BIO-TECHNE CORPORATION
    • TABLE 323 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 43 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2020)
    • 11.1.7 ABCAM PLC
    • TABLE 324 ABCAM PLC: BUSINESS OVERVIEW
    • FIGURE 44 ABCAM PLC: COMPANY SNAPSHOT (2020)
    • 11.1.8 BECTON, DICKINSON AND COMPANY
    • TABLE 325 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
    • FIGURE 45 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
    • 11.1.9 PERKINELMER, INC.
    • TABLE 326 PERKINELMER, INC.: BUSINESS OVERVIEW
    • FIGURE 46 PERKINELMER, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.10 TAKARA BIO, INC.
    • TABLE 327 TAKARA BIO, INC.: BUSINESS OVERVIEW
    • FIGURE 47 TAKARA BIO, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.11 THERMO FISHER SCIENTIFIC, INC.
    • TABLE 328 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
    • FIGURE 48 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2020)
    • 11.1.12 PHC HOLDINGS CORPORATION
    • TABLE 329 PHC HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • 11.1.13 CELL SIGNALING TECHNOLOGY, INC.
    • TABLE 330 CELL SIGNALING TECHNOLOGY, INC.: BUSINESS OVERVIEW
    • 11.1.14 BIO SB, INC.
    • TABLE 331 BIO SB, INC.: BUSINESS OVERVIEW
    • 11.1.15 MILTENYI BIOTEC
    • TABLE 332 MILTENYI BIOTEC: BUSINESS OVERVIEW
    • 11.1.16 CANDOR BIOSCIENCE GMBH
    • TABLE 333 CANDOR BIOSCIENCE GMBH: BUSINESS OVERVIEW
    • 11.1.17 SAKURA FINETEK JAPAN CO., LTD.
    • TABLE 334 SAKURA FINETEK JAPAN CO., LTD.: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 EAGLE BIOSCIENCES, INC.
    • TABLE 335 EAGLE BIOSCIENCES, INC.: COMPANY OVERVIEW
    • 11.2.2 BIOCARE MEDICAL, LLC
    • TABLE 336 BIOCARE MEDICAL, LLC: COMPANY OVERVIEW
    • 11.2.3 ELABSCIENCE, INC.
    • TABLE 337 ELABSCIENCE, INC.: COMPANY OVERVIEW
    • 11.2.4 BIO-GENEX LABORATORIES
    • TABLE 338 BIO-GENEX LABORATORIES: COMPANY OVERVIEW
    • 11.2.5 DIAGNOSTIC BIOSYSTEMS, INC.
    • TABLE 339 DIAGNOSTIC BIOSYSTEMS, INC.: COMPANY OVERVIEW
    • 11.2.6 BIOVISION, INC.
    • TABLE 340 BIOVISION, INC.: COMPANY OVERVIEW
    • 11.2.7 ROCKLAND IMMUNOCHEMICALS, INC.
    • TABLE 341 ROCKLAND IMMUNOCHEMICALS, INC.: COMPANY OVERVIEW
    • 11.2.8 GENEMED BIOTECHNOLOGIES, INC.
    • TABLE 342 GENEMED BIOTECHNOLOGIES, INC.: COMPANY OVERVIEW
  • *Business overview, Products and Services offered, Recent developments, MNM view might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS